
Levicent 500mg Injection
Marketer
Crescent Therapeutics Ltd
Salt Composition
Levetiracetam (500mg)
Overview Levicent 500mg Injection
Epileptic seizures are managed with the anticonvulsant Levecent 500mg Injection. Administered intravenously as a slow infusion by a medical professional, it offers short-term seizure control when oral medication is impractical, such as in unconscious patients. Levecent is effective only while consistently used; discontinuation or missed doses may exacerbate seizures. Long-term seizure management typically transitions to oral medication following injection therapy. Common side effects, often subsiding after initial use, include drowsiness, headache, infection, localized irritation, nasal congestion, and decreased appetite. Behavioral changes, including aggression and irritability, are also possible. Seek immediate medical attention for allergic reactions (rash, swelling, breathing difficulties, hives), persistent behavioral changes (confusion, irritability, increased aggression), or suicidal thoughts. Inform your physician of kidney issues, depression, suicidal ideation, or pregnancy before commencing treatment. Alcohol should be avoided due to increased seizure risk and amplified side effects. Drowsiness and dizziness may impair driving or operating machinery. Regular kidney function monitoring may be necessary.
Primary Ingredients of Levicent 500mg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Levicent 500mg Injection
Managing Epileptic Seizures
Major Benefits of Levicent 500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Levicent 500mg Injection:
- Sleepiness
- Dizziness
- Decreased appetite
- Fatigue
- Headache
- Behavioral changes
- Irritation
- Aggressive behavior
- Agitation
- Infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
How to use Levicent 500mg Injection:
The medication will be administered by your physician or their registered nurse. Self-medication is strongly discouraged.
How Levicent 500mg Injection works:
Epileptic seizures are managed by Levicent 500mg Injection, an anticonvulsant. Its mechanism involves binding to neuronal SV2A receptors, thus inhibiting aberrant brain cell activity and preventing the propagation of seizure-inducing electrical impulses.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Levicent 500mg Injection poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
Administering Levicent 500mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescription. Physician consultation is recommended.
Breast feedingSAFE IF PRESCRIBED
Administering Levicent 500mg Injection while breastfeeding appears to pose minimal risk. Available human data indicate negligible infant harm. Closely observe the infant for drowsiness and satisfactory weight increase.
DrivingUNSAFE
Administering Levicent 500mg Injection might cause drowsiness, visual disturbances, and dizziness. Driving is inadvisable if such effects manifest.
KidneyCAUTION
Administering Levicent 500mg Injection requires careful consideration in individuals with impaired renal function. Dosage modification of Levicent 500mg Injection might be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of 500mg Levicent injections in individuals with liver conditions is likely safe. Available evidence indicates dose modification may be unnecessary for most, but a reduced dosage might be recommended for those with severe hepatic impairment. Physician consultation is advised.
What if you forget to take Levicent 500mg Injection :
Should you forget a Levicent 500mg Injection, administer it immediately. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Levicent 500mg Injection
| Label | Value |
|---|---|
| Chemical Category | Pyrrolidinone-Acetamide Hybrid |
| Developing Habits | No. |
| Type of Therapy | Neuroscience and Central Nervous System |
| Actions | AED: A protein ligand in synaptic vesicle 2 |
